Management of systemic malignancies metastatic to the eye and orbit

Keyphrases

• Lymphoma 100%
• Ophthalmologist 100%
• Leukemia 100%
• Long-term Survival 100%
• Proptosis 100%
• Systemic Malignancy 100%
• Solid Tumors 50%
• Early Detection 50%
• Thrombocytopenia 50%
• Localized Disease 50%
• Prognostic Criteria 50%
• Metastatic Disease 50%
• Neoplasms 50%
• Anemia 50%
• Breast Carcinoma 50%
• Complete Remission 50%
• Histopathological Features 50%
• Lung Carcinoma 50%
• Patients with Cancer 50%
• Diplopia 50%
• Palpable Mass 50%
• Conjunctival 50%
• Ocular Morbidity 50%
• Anatomic Site 50%
• Orbital Diseases 50%
• Oncologists 50%
• Quality of Life Improvement 50%
• Site of Involvement 50%
• Intraocular Lymphoma 50%
• External Radiation 50%
• Neoplastic Disorders 50%
• Overall Morbidity 50%
• Poor Prognostic 50%
• Adnexal Structures 50%
• Ocular Adnexa 50%
• Radiosensitive 50%
• Prognostic Indicator 50%
• Chronic Uveitis 50%
• Leukemic Infiltration 50%
• Eye Structure 50%
• Ocular Metastasis 50%
• Ocular Presentations 50%
• Symptom Resolution 50%
• Masquerade 50%
• Radiation Therapist 50%
• Therapeutic Modalities 50%
• Vision Loss 50%

Medicine and Dentistry

• Cancer 100%
• Metastatic Carcinoma 100%
• Leukemia 100%
• Long Term Survival 100%
• Exophthalmos 100%
• Solid Malignant Neoplasm 50%
• Neoplasm 50%
• Thrombocytopenia 50%
• Anemia 50%
• Breast Carcinoma 50%
• Lung Carcinoma 50%
• Disease 50%
• Diplopia 50%
• Orbit Disease 50%
• Therapeutic Modality 50%
• Oncologist 50%
• Leukemic Infiltration 50%
• Quality of Life 50%
• Localized Disease 50%
• Uveitis 50%
• Adnexa 50%
• Intraocular Lymphoma 50%
• Choroid 50%